Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
01/08/2002 | US6337326 N-aryl-(homopiperazinyl)-cyclohexyl amines |
01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
01/03/2002 | WO2002000649A1 Substituted quinazoline derivatives and their use as inhibitors |
01/03/2002 | WO2002000647A1 Heteroaryl-phenyl substituted factor xa inhibitors |
01/03/2002 | WO2002000646A1 Fatty acid synthase inhibitors |
01/03/2002 | WO2002000644A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
01/03/2002 | WO2002000621A1 Compounds exhibiting x-type spla2 inhibiting effect |
01/03/2002 | WO2002000606A1 Biphenyl compound |
01/03/2002 | WO2002000256A1 Remedies for cirrhosis |
01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
01/03/2002 | WO2001045689A3 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
01/03/2002 | US20020002195 Pesticidal 1-polyarylpyrazoles |
01/03/2002 | US20020002169 Protein kinase inhibitors |
01/03/2002 | US20020002163 1,4-benzodiazepinones and their uses as CCK antagonists |
01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
01/03/2002 | CA2412592A1 Substituted quinazoline derivatives and their use as inhibitors |
01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
01/03/2002 | CA2409762A1 Heteroaryl-phenyl substituted factor xa inhibitors |
01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/02/2002 | EP1165523A1 Neurotrophic substituted pyrimidines |
01/02/2002 | EP1165518A2 Benzimidazole and imidazolopyridine derivatives, their preparation and their use as selective modulators of bradykinin b2 (= bk-2) receptors |
01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
01/02/2002 | EP1165013A2 Inhibitors of prenyl-protein transferase |
01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
01/02/2002 | EP0835256B1 Microbicidal benzotriazoles |
01/02/2002 | EP0731091B1 2-oxoindoline derivatives as cholecystokinin receptor antagonists |
01/02/2002 | CN1329609A Tetrahydrobenza epine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
01/02/2002 | CN1329491A Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants |
01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
01/02/2002 | CN1328824A Compound for curing female sexual disorder |
01/02/2002 | CN1077104C Palladium catalyzed ring closure of triazolyl tryptamine |
01/01/2002 | USRE37495 As pesticide, insecticide |
01/01/2002 | US6335432 For fluorescent hybridization probes for use in diagnosis, research, and therapy |
01/01/2002 | US6335357 1-aryl-3-cyano-5-(het)arylalkylaminopyrazole derivatives; insecticides for agriculture and horticulture |
01/01/2002 | US6335343 Inhibitors of prenyl-protein transferase |
01/01/2002 | US6335340 compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses |
01/01/2002 | US6335336 Treating tumor necrosis factor and mitogen-activated protein kinase(map) mediated disorders; antiinflammatory and antiarthritic agents; inflammatory bowel disease |
01/01/2002 | US6335332 Barbituric acid derivatives with antimetastatic and antitumor activity |
01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
01/01/2002 | US6335324 Treating asthma or allergic rhinitis |
01/01/2002 | CA2215333C Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists |
01/01/2002 | CA2029105C Halogenated sulphonylaminocarbonyltriazolinones |
12/29/2001 | CA2351897A1 Use of growth hormone secretagogues for treatment of physical performance decline |
12/27/2001 | WO2001098296A2 2-(3,5-disubstituted-4-pyridyl)-4-(thienyl, thiazolyl or arylphenyl)-1,3-oxazoline compounds |
12/27/2001 | WO2001098295A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
12/27/2001 | WO2001098294A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
12/27/2001 | WO2001098278A1 Methods and compositions utilizing quinazolinones |
12/27/2001 | WO2001098277A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
12/27/2001 | WO2001098272A1 Novel compounds |
12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
12/27/2001 | WO2001098267A1 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
12/27/2001 | WO2001097861A2 Vitronectin receptor antagonist pharmaceuticals |
12/27/2001 | WO2001097807A1 New use of angiotensin ii antagonists |
12/27/2001 | WO2001097790A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
12/27/2001 | WO2001053268A3 Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
12/27/2001 | US20010056110 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
12/27/2001 | US20010056103 Non-immunosuppressive, piperidino or pyrrolidino amide derivative has an affinity for an FKBP-type immunophilin, useful for treating Alzheimer's Disease, Huntington's Disease, Parkinson's Disease, amyotrophic lateral sclerosis |
12/27/2001 | US20010056093 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
12/27/2001 | US20010055567 Uses water-soluble dyes and their biomolecule adducts, each having specific photophysical and pharmaco-chemical properties, as contrast media for fluorescence and transillumination diagnostics |
12/27/2001 | CA2413957A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
12/27/2001 | CA2412188A1 3-azabicyclo¬3.1.0|hexane derivatives useful in therapy |
12/27/2001 | CA2411553A1 New use of angiotensin ii antagonists |
12/27/2001 | CA2411255A1 Novel compounds |
12/26/2001 | CN1328554A Eletriptan hydrobromide monohydrate |
12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
12/26/2001 | CN1328471A Near infrared fluorescent contrast agent and fluorescence imaging |
12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
12/26/2001 | CN1327984A Substituted triazole, imidazole or pyrazole herbicides |
12/25/2001 | US6333344 Prolines as antimicrobial agents |
12/25/2001 | US6333325 Method of treating cytokine mediated diseases or conditions |
12/25/2001 | US6333323 Indole derivatives with antiviral activity |
12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
12/25/2001 | CA2052424C 2-(4-piperidinyl)-1h-pyrido¬4,3-b|indol-1-ones and related compounds, intermediates and a process for their preparation |
12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
12/20/2001 | WO2001096323A1 Serine protease inhibitors |
12/20/2001 | WO2001096304A1 Serine protease inhibitors |
12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
12/20/2001 | WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments |
12/20/2001 | WO2001095911A1 Protease inhibitors |